General Session

The Outpatient ALL Blueprint: Scaling Low Toxicity T-Cell Redirection in the Community

45 min
Tuesday, October 13, 2026
8:35 AM - 9:20 AM
Supported by educational grants from AstraZeneca and Autolus Therapeutics.
  • Room
    • Broadway South
share
Back to top